Simple Quantification of Surface Uptake in F-18 Florapronol PET/CT Imaging for the Validation of Alzheimer’s Disease

Simple Quantification of Surface Uptake in F-18 Florapronol PET/CT Imaging for the Validation of Alzheimer’s Disease

We developed a novel quantification method named shape feature using F-18 florapronol positron emission tomography–computed tomography (PET/CT) and evaluated its sensitivity and specificity for discriminating between patients with Alzheimer’s disease (AD) and patients with mild cognitive impairment...

Full description

Bibliographic Details
Main Authors:	Do-Hoon Kim, Junik Son, Chae Moon Hong, Ho-Sung Ryu, Shin Young Jeong, Sang-Woo Lee, Jaetae Lee
Format:	Article
Language:	English
Published:	MDPI AG 2022-01-01
Series:	Diagnostics
Subjects:	beta-amyloid positron emission tomography F-18 florapronol Alzheimer’s disease cerebral amyloid smoothing score brain atrophy index
Online Access:	https://www.mdpi.com/2075-4418/12/1/132

Similar Items

Amyloid beta plaque accumulation with longitudinal [18F]AZD4694 PET
by: Joseph Therriault, et al.
Published: (2023-07-01)

Predicting amyloid PET positivity using plasma p‐tau181 and other blood‐based biomarkers
by: Hyuk Sung Kwon, et al.
Published: (2023-10-01)

Amyloid proteins : methods and protocols /
by: Sigurdsson, Einar M.
Published: (2005)

Operationalizing the centiloid scale for [18F]florbetapir PET studies on PET/MRI
by: William Coath, et al.
Published: (2023-04-01)

Comparison of plasma p-tau217 and p-tau181 in predicting amyloid positivity and prognosis among Korean memory clinic patients
by: Hyuk Sung Kwon, et al.
Published: (2025-03-01)

Establishing cutoff values for visual amyloid positivity in [18F]flutemetamol PET
by: Yong-Jin Park, et al.
Published: (2025-01-01)

Amyloid PET Radiopharmaceuticals and Imaging for Clinical and Research Applications in Thailand
by: Tossaporn Siriprapa, et al.
Published: (2023-09-01)

Validation of 3‐ and 5‐point severity scales to assess ARIA‐E
by: Luc Bracoud, et al.
Published: (2023-10-01)

Patterns of Focal Amyloid Deposition Using <sup>18</sup>F-Florbetaben PET in Patients with Cognitive Impairment
by: Sung-eun Chung, et al.
Published: (2022-05-01)

Amyloid and tau PET in cerebral amyloid angiopathy-related inflammation two case reports and literature review
by: Jhih-Yong Yang, et al.
Published: (2023-04-01)

Probabilistic estimation for across‐batch compatibility enhancement for amyloid PET
by: Murat Bilgel
Published: (2023-07-01)

The effects of amyloid beta aggregation on neuronal transcription
by: Jesse St. Jean, et al.
Published: (2023-06-01)

Astrogliosis instigated signature in neurodegenerative diseases: Supremacy of GFAP in forecasting structural pathology and disease progression in Alzheimer’s disease
by: Sri Harsha Kanuri, et al.
Published: (2024-07-01)

Gray to white matter signal ratio as a novel biomarker of neurodegeneration in Alzheimer’s disease
by: Deepti Putcha, et al.
Published: (2023-01-01)

Social relationships, amyloid burden, and dementia: The ARIC‐PET study
by: Renée C. Groechel, et al.
Published: (2024-04-01)

Sleep duration, sleep efficiency, and amyloid β among cognitively healthy later-life adults: a systematic review and meta-analysis
by: Chooza Moon, et al.
Published: (2024-05-01)

Development of Amyloid PET Analysis Pipeline Using Deep Learning-Based Brain MRI Segmentation—A Comparative Validation Study
by: Jiyeon Lee, et al.
Published: (2022-03-01)

Evaluation of a novel PET tracer [18F]-Florbetazine for Alzheimer's disease diagnosis and β-amyloid deposition quantification
by: Meiqi Wu, et al.
Published: (2024-09-01)

Looking for a generic inhibitor of amyloid-like fibril formation among flavone derivatives
by: Tomas Šneideris, et al.
Published: (2015-09-01)

Amyloid proteins : the beta sheet conformation and disease /
by: Sipe, Jean D.
Published: (2005)

Amyloid precursor protein : a practical approach /
by: Xia, Weiming, et al.
Published: (2005)

Prognostic Role of CSF β-amyloid 1–42/1–40 Ratio in Patients Affected by Amyotrophic Lateral Sclerosis
by: Tiziana Colletti, et al.
Published: (2021-02-01)

Glucoraphanin Triggers Rapid Antidepressant Responses in a Rat Model of Beta Amyloid-Induced Depressive-like Behaviour
by: Paolo Tucci, et al.
Published: (2022-08-01)

Oligomeric and fibrillar amyloid beta 42 induce platelet aggregation partially through GPVI
by: O. Elaskalani, et al.
Published: (2018-05-01)

Different associations between amyloid-βeta 42, amyloid-βeta 40, and amyloid-βeta 42/40 with soluble phosphorylated-tau and disease burden in Alzheimer’s disease: a cerebrospinal fluid and fluorodeoxyglucose-positron emission tomography study
by: Caterina Motta, et al.
Published: (2023-08-01)

A universal neocortical mask for Centiloid quantification
by: Pierrick Bourgeat, et al.
Published: (2023-07-01)

Development of software for measuring brain amyloid accumulation using 18F‐florbetapir PET and calculating global Centiloid scale and regional Z‐score values
by: Hiroshi Matsuda, et al.
Published: (2023-07-01)

Prion meeting 2023: implications of a growing field
by: Tiago F. Outeiro, et al.
Published: (2024-12-01)

Amyloidosis in Alzheimer’s Disease: Pathogeny, Etiology, and Related Therapeutic Directions
by: Chen Ma, et al.
Published: (2022-02-01)

Multi-pathological contributions toward atrophy patterns in the Alzheimer’s disease continuum
by: Rosaleena Mohanty, et al.
Published: (2024-04-01)

Combining plasma Aβ and p-tau217 improves detection of brain amyloid in non-demented elderly
by: Yoshiki Niimi, et al.
Published: (2024-05-01)

Case Report: Taxifolin for neurosurgery-associated early-onset cerebral amyloid angiopathy
by: Maxwell C. Y. Choi, et al.
Published: (2024-03-01)

Moderation of thyroid hormones for the relationship between amyloid and tau pathology
by: Jeong Hyeon Byeon, et al.
Published: (2024-07-01)

Effect of Cholesterol Molecules on Aβ1-42 Wild-Type and Mutants Trimers
by: Trung Hai Nguyen, et al.
Published: (2022-02-01)

Role of Alginate Composition on Copper Ion Uptake in the Presence of Histidine or Beta-Amyloid
by: Cynthia Regina Albrecht Mahl, et al.
Published: (2022-11-01)

Amyloid Beta Oligomers Activate Death Receptors and Mitochondria-Mediated Apoptotic Pathways in Cerebral Vascular Smooth Muscle Cells; Protective Effects of Carbonic Anhydrase Inhibitors
by: Amy Anzovino, et al.
Published: (2023-12-01)

Disentangling tau and brain atrophy cluster heterogeneity across the Alzheimer's disease continuum
by: Jon B. Toledo, et al.
Published: (2022-01-01)

Crystal Violet Selectively Detects Aβ Oligomers but Not Fibrils In Vitro and in Alzheimer’s Disease Brain Tissue
by: Kanchana Karunarathne, et al.
Published: (2024-05-01)

A Copper-Selective Sensor and Its Inhibition of Copper-Amyloid Beta Aggregation
by: Ngoc Kim Nguyen, et al.
Published: (2024-05-01)

Interplay between epigallocatechin-3-gallate and ionic strength during amyloid aggregation
by: Mantas Ziaunys, et al.
Published: (2021-10-01)